|
EIF2B3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.571100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.383700E-03 |
| Normal-vs-Stage2 |
4.797800E-02 |
| Normal-vs-Stage3 |
3.984000E-03 |
| Normal-vs-Stage4 |
1.990610E-04 |
| Stage1-vs-Stage2 |
9.332000E-01 |
| Stage1-vs-Stage3 |
2.230000E-01 |
| Stage1-vs-Stage4 |
1.209190E-01 |
| Stage2-vs-Stage3 |
3.509800E-01 |
| Stage2-vs-Stage4 |
1.154800E-01 |
| Stage3-vs-Stage4 |
5.232400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.760570E-04 |
| Normal-vs-AfricanAmerican |
4.492400E-02 |
| Normal-vs-Asian |
4.366800E-01 |
| Caucasian-vs-AfricanAmerican |
1.652010E-01 |
| Caucasian-vs-Asian |
8.680600E-01 |
| AfricanAmerican-vs-Asian |
7.667800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.60959999999855E-05 |
| Normal-vs-Female |
3.360600E-01 |
| Male-vs-Female |
4.612700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.981400E-03 |
| Normal-vs-Extreme_Weight |
9.363500E-03 |
| Normal-vs-Obese |
2.958800E-03 |
| Normal-vs-Extreme_Obese |
3.820400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.876200E-01 |
| Normal_Weight-vs-Obese |
9.082200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.840400E-01 |
| Extreme_Weight-vs-Obese |
6.708400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.491210E-01 |
| Obese-vs-Extreme_Obese |
2.890200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.130100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.612720E-04 |
| Normal-vs-Age(61-80Yrs) |
6.824800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.979300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.668000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.123200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.265800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.529620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.701200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.552200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.497460E-03 |
| Normal-VS-Type2 PRCC |
3.655700E-03 |
| Normal-VS-KIRP CIMP |
1.083150E-03 |
| Normal-VS-Unclassified PRCC |
1.304430E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.854600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.081000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.194200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.517000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.365000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.718000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.295690E-03 |
| Normal-vs-N1 |
2.001200E-04 |
| Normal-vs-N2 |
5.260400E-01 |
| N0-vs-N1 |
3.370400E-01 |
| N0-vs-N2 |
8.525800E-01 |
| N1-vs-N2 |
5.391200E-01 |
|
|
